Octreotide: A therapeutic option for idiopathic intracranial hypertension

Neurology, Neurophysiology and Neuroscience

Volumn 2007, Issue , 2007, Pages

  Panagopoulos, G N ^a   Deftereos, Spyros N ^a,b   Tagaris, G A ^a   Grillia, M ^a   Kounadi, T ^a   Karamani, O ^a   Panagiotidis, D ^a   Koutiola Pappa, E ^a   Karageorgiou, C E ^a   Piadites, G ^a  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Idiopathic intracranial hypertension; Octreotide; Somatostatin; Treatment

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; IDIOPATHIC DISEASE; INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OPHTHALMOSCOPY; PAPILLEDEMA; PROSPECTIVE STUDY; SYMPTOM; VISUAL ACUITY; VISUAL DISORDER; VISUAL FIELD;

EID: 34547178765     PISSN: 15268748     EISSN: 19331266     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Alex K Ball, Carl E Clarke. Idiopathic intracranial hypertension. Lancet Neurol 2006;5:433-42.
2. Antaraki A, Piadites G, Vergados J, Andreou A, Chlouverakis C. Octreotide in benign intracranial hypertention. Lancet 1993: 342:1170.
3. Battershill PE, Clissold SP. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs 1 989:38:658-702.
4. Corbett JJ, Digre KB. Idiopathic intracranial hypertension: An answer to, "the chicken or the egg?" Neurology 2002:58:5-6.
5. Digre KB, Corbett JJ. Idiopathic intracranial hypertension (pseudotumor cerebri): A reappraisal. Neurologist 2001:7:2-67.
6. Ichimiya Y, Emson PC, Northrop AJ, Gilmour RS. Insulin-like growth factor II in the rat choroid plexus. Brain Res 1988:464:167-70.
7. Johnstone I. Reduced CSF absorption syndrome. Reappraisal of benign intracranial hypertension and related conditions. Lancet 1973:418-20.
8. Kapicioglu S,Gokce E,Kapicioglu Z,Ovali E. Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia 1997:Feb;17(1):27-30.
9. King JO, Mitchell PJ, Thompson KR, Tress BM. Cerebral renography and manometry in idiopathic intracranial hypertension. Neurology 1995:45:2224-8.
10. King JO, Mitchell PJ, Thomson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002:58:26-30.
11. Lamberts SWI, van der Hely A-J, de Herder WW, Hofland LJ. Octreotide. N Engl J Med 1996:334:246-54.
12. Lopponen T, Saukkonen AL, Serlo W, Tapanainen P, Ruokonen A, Lanning P, et al. Pituitary function in children with hydrocephalus before and after the first shunting operation. Eur J Endocrinol 1998:138:170-5.
13. Lueck C,McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev 2005:(3);CD003434.
14. Malozowski S, Tanner LA, Wysowski D, Fleming GA. Growth Hormone, Insulin-like growth factor I and benign intracranial hypertension. N Engl J Med 1993:329:665-6.
15. Matharu MS, Levy MJ,Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study.Ann Neurol 2004:Oct;56(4):488-94.
16. Mathew NT, Meyer JS, Otto EO. Increased cerebral blood volume in benign intracranial hypertension. Neurology 1975:25:646-9.
17. Plewe G, Beyer J, Krause U, Neufeld M, del Pozo E. Long-acting and selective suppression of growth factor hormone secretion by somatostatin analogue SMS 201-995 in acromegaly. Lancet 1984:2:782-4.
18. Price DA, Clayton PE, Lloyd IC. Benign Intracranial Hypertension induced by Growth Hormone Treatment. Lancet 1995:345;458-9.
19. Sahs AL, Joynt RJ. Brain swelling of unknown cause. Neurology 1956:6;791-803.
20. Sandler LM, Burrin JM, Williams G, Joplin GF, Carr DH, Bloom SR. Effective long-term treatment of acromegaly with a long-acting somatostatin analogue (SMS 201-995). Clin Endocrinol 1987:26;85-95.
21. Tauber JP, Babin T, Tauber MT, Vigoni F, Bonafe A, Ducasse M, et al. Long-term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly. J Clin Endocrinol Metab 1989:68:917-24.
22. Williams G, Ball JA, Lawson RA, Joplin GF, Bloom SR, Maskill MR. Analgesic effects of somatostatin analogue (octreotide) in headache associated with pituitary tumors. Br Med J 1987:295:247-8.